Skip to content

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Oct 2026

The evolving landscape of DLL3-directed Therapeutics in small cell lung cancer.

Small cell lung cancer (SCLC) remains one of the most lethal thoracic malignancies, characterized by rapid progression, early metastasis, and limited durable responses to conventional therapy. Delta-like ligand 3 (DLL3), a Notch pathway inhibitory ligand aberrantly overexpressed on the surface of approximately 70-85% o...

Vivian Tieu, Z. Arter, M. Nagasaka · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.